Tarveda Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Tarveda Therapeutics's estimated annual revenue is currently $1.1M per year.
- Tarveda Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Tarveda Therapeutics has 7 Employees.
- Tarveda Therapeutics grew their employee count by 0% last year.
Tarveda Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Clinical Operations | Reveal Email/Phone |
Tarveda Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Tarveda Therapeutics?
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tarveda Therapeutics News
2022-04-13 - Global Small-cell Lung Cancer Pipeline Insight | Clinical Trials Evaluation
Research Report 2022 by DelveInsight
... 100+ Small-cell Lung Cancer treatment therapies, analyzes DelveInsight ... Harpoon Therapeutics, Genprex, Inc., Tarveda Therapeutics,...
2022-04-06 - Biopharm Co. Tarveda To Liquidate In Del. Chancery Court
Tarveda Therapeutics Inc.'s filing for court recognition of its ABC a process used at times as an alternative to bankruptcy liquidation...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 7 | 0% | $36M |
#2 | $0.9M | 7 | 0% | N/A |
#3 | $0.1M | 7 | 0% | $6.1M |
#4 | $0.1M | 7 | -12% | $12M |
#5 | $3.5M | 7 | -30% | N/A |